share_log

HC Wainwright & Co. Maintains Buy on ITeos Therapeutics, Lowers Price Target to $44

HC Wainwright & Co. Maintains Buy on ITeos Therapeutics, Lowers Price Target to $44

HC Wainwright & Co.维持对iTeos Therapeutics的买入,将目标股价下调至44美元
Benzinga ·  2023/08/09 06:23

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains ITeos Therapeutics (NASDAQ:ITOS) with a Buy and lowers the price target from $54 to $44.

HC Wainwright & Co. 分析师Swayampakula Ramakanth维持iTeos Therapeutics(纳斯达克股票代码:ITOS)的买入,并将目标股价从54美元下调至44美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发